❖ Scientists have developed the “holy grail” diabetes treatments - a “smart” insulin that responds in real time to fluctuations in one’s blood sugar level.

❖ The newly developed NNC2215 is effective as human insulin at lowering blood glucose in rats and pigs.

❖ The engineered insulin requires a significant glucose spike to be activated, and once it is activated, there is a sudden rush of insulin in the system.

❖ Type 1 diabetes, which often starts in childhood, occurs when the pancreas does not produce insulin (or enough insulin).

❖ Type 2 diabetes sees the cells of the body develop resistance to insulin, meaning greater amounts are required that what is produced by the pancreas.